$BRGX SEC Filings

Filed On	Filing
20 May 2026	FORM 10-Q FOR MAR 2026
15 May 2026	EXTENSION
15 Apr 2026	FORM 10-K FOR DEC 2025
01 Apr 2026	EXTENSION
14 Nov 2025	FORM 10-Q FOR SEP 2025
14 Aug 2025	FORM 10-Q FOR JUNE 2025
15 May 2025	FORM 10-Q FOR MAR 2025
16 Apr 2025	FORM 10-K FOR DEC 2024
15 Apr 2025	FORM 10-K FOR DEC 2024
14 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
01 Apr 2025	NT 10-K
22 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
02 Jan 2025	Form 3: Janney Richard, Director No securities owned
14 Nov 2024	FROM 10-Q FOR SEPT 2024
11 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation
09 Oct 2024	FORM 10-Q FOR JUNE 2024
09 Oct 2024	FORM 10-Q AMENDMENT 2
09 Oct 2024	8-K/A: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +3 more We have audited the accompanying consolidated balance sheets of Bioregenx, Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, stockholders’ equity (deficiency), and cash flows for th...
12 Aug 2024	EXTENSION
23 Jul 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments